目的探讨老年重症脑卒中患者发生多器官功能障碍综合征(multiple organ dysfunction syndrome,MODS)的危险因素。方法前瞻性选择2020年1月至2022年12月广东医科大学附属医院收治的老年重症脑卒中患者112例。根据入院后14 d内多器官功能...目的探讨老年重症脑卒中患者发生多器官功能障碍综合征(multiple organ dysfunction syndrome,MODS)的危险因素。方法前瞻性选择2020年1月至2022年12月广东医科大学附属医院收治的老年重症脑卒中患者112例。根据入院后14 d内多器官功能评分系统分为MODS组38例,非MODS组74例。根据最终预后又分为生存组33例和死亡组79例。收集患者一般临床资料、急性生理学与慢性健康状况评估Ⅱ(acute physiology and chronic health evaluation,APACHEⅡ)评分、格拉斯哥昏迷评分(Glasgow coma scale,GCS)和头颅影像学参数。采用logistic回归分析MODS发生的危险因素。结果MODS组脑卒中/脑出血、慢性阻塞性肺疾病、冠心病、吸烟、美国国立卫生研究院卒中量表(National Institute of Health Stroke Scale,NIHSS)评分、APACHEⅡ评分、多支血管病变、尿路感染、静脉血栓、出血、癫痫、心肌梗死、急性期机械通气、渗透疗法和住院病死率明显高于非MODS组,GCS明显低于非MODS组,差异有统计学意义(P<0.05,P<0.01)。二元logistic回归分析显示,NIHSS评分、APACHEⅡ评分及多支血管病变是MODS发生的独立危险因素(OR=1.124,95%CI:1.121~1.163,P=0.015;OR=1.265,95%CI:1.296~1.426,P=0.001;OR=2.532,95%CI:1.126~5.013,P=0.026)。死亡组MODS评分、APACHEⅡ评分明显高于生存组,差异有统计学意义(P<0.05)。结论老年重症脑卒中患者急性期易发生MODS。展开更多
Systemic inflammatory response syndrome (SIRS) and its lethal sequela multiple organ dysfunction syndrome (MODS) are common complications in critical illness, such as severe trauma, shock, infection and major operatio...Systemic inflammatory response syndrome (SIRS) and its lethal sequela multiple organ dysfunction syndrome (MODS) are common complications in critical illness, such as severe trauma, shock, infection and major operations. During the past three decades, the evolution in our understanding of SIRS and/or MODS could be divided into three stages. Particularly in recent years, advances in molecular and cellular biology have provided new insights in the pathogenesis of this complex condition. The earlier emphasis on the pro inflammatory mediators involved in propagation of inflammatory response, has gradually been replaced by a realization that SIRS/MODS are the result of an imbalance of pro and anti inflammatory mediators to create the final status of excessive inflammation or immunoparalysis’. Though prognosis remains poor, the knowledge that now exists about SIRS/MODS gives great hope for the future. Progress has been made in new treatment modalities and re evaluation of current available measures. Nevertheless, improved techniques to monitor immunological or other markers of inflammatory and host defense responses will be important in assessing the effects of future therapies on central mechanisms contributing to SIRS/MODS.展开更多
文摘目的探讨老年重症脑卒中患者发生多器官功能障碍综合征(multiple organ dysfunction syndrome,MODS)的危险因素。方法前瞻性选择2020年1月至2022年12月广东医科大学附属医院收治的老年重症脑卒中患者112例。根据入院后14 d内多器官功能评分系统分为MODS组38例,非MODS组74例。根据最终预后又分为生存组33例和死亡组79例。收集患者一般临床资料、急性生理学与慢性健康状况评估Ⅱ(acute physiology and chronic health evaluation,APACHEⅡ)评分、格拉斯哥昏迷评分(Glasgow coma scale,GCS)和头颅影像学参数。采用logistic回归分析MODS发生的危险因素。结果MODS组脑卒中/脑出血、慢性阻塞性肺疾病、冠心病、吸烟、美国国立卫生研究院卒中量表(National Institute of Health Stroke Scale,NIHSS)评分、APACHEⅡ评分、多支血管病变、尿路感染、静脉血栓、出血、癫痫、心肌梗死、急性期机械通气、渗透疗法和住院病死率明显高于非MODS组,GCS明显低于非MODS组,差异有统计学意义(P<0.05,P<0.01)。二元logistic回归分析显示,NIHSS评分、APACHEⅡ评分及多支血管病变是MODS发生的独立危险因素(OR=1.124,95%CI:1.121~1.163,P=0.015;OR=1.265,95%CI:1.296~1.426,P=0.001;OR=2.532,95%CI:1.126~5.013,P=0.026)。死亡组MODS评分、APACHEⅡ评分明显高于生存组,差异有统计学意义(P<0.05)。结论老年重症脑卒中患者急性期易发生MODS。
文摘Systemic inflammatory response syndrome (SIRS) and its lethal sequela multiple organ dysfunction syndrome (MODS) are common complications in critical illness, such as severe trauma, shock, infection and major operations. During the past three decades, the evolution in our understanding of SIRS and/or MODS could be divided into three stages. Particularly in recent years, advances in molecular and cellular biology have provided new insights in the pathogenesis of this complex condition. The earlier emphasis on the pro inflammatory mediators involved in propagation of inflammatory response, has gradually been replaced by a realization that SIRS/MODS are the result of an imbalance of pro and anti inflammatory mediators to create the final status of excessive inflammation or immunoparalysis’. Though prognosis remains poor, the knowledge that now exists about SIRS/MODS gives great hope for the future. Progress has been made in new treatment modalities and re evaluation of current available measures. Nevertheless, improved techniques to monitor immunological or other markers of inflammatory and host defense responses will be important in assessing the effects of future therapies on central mechanisms contributing to SIRS/MODS.
